We are live on ! Find out more
PAWC

P.A.W. Capital Portfolio holdings

AUM $131M
1-Year Est. Return 46.14%
This Fund
S&P 500
This Quarter Est. Return
-0.33%
1 Year Est. Return
+46.14%
3 Year Est. Return
+67.18%
5 Year Est. Return
+64.85%
10 Year Est. Return
+1,459.33%
AUM
$109M
AUM Growth
-$3.38M
Cap. Flow
+$2.74M
Cap. Flow %
2.52%
Top 10 Hldgs %
48.05%
Holding
68
New
5
Increased
17
Reduced
21
Closed
8

Top Buys

Rank Stock Value
1
MGNI icon
Magnite
MGNI
+$3.38M
2
ONTF
ON24
ONTF
+$2.68M
3
INDI icon
indie Semiconductor
INDI
+$2.54M
4
CHGG icon
Chegg
CHGG
+$2.23M
5
DXC icon
DXC Technology
DXC
+$1.3M

Top Sells

Rank Stock Value
1
AMBA icon
Ambarella
AMBA
+$1.85M
2
IOVA icon
Iovance Biotherapeutics
IOVA
+$1.85M
3
CCCC icon
C4 Therapeutics
CCCC
+$1.79M
4
LPSN icon
LivePerson
LPSN
+$1.47M
5
RTB
RTB Digital
RTB
+$1.41M

Sector Composition

Rank Sector Weight
1 Technology 35.99%
2 Communication Services 16.8%
3 Healthcare 15.05%
4 Industrials 12.61%
5 Consumer Staples 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSCO icon
26
Cisco
CSCO
$457B
$951K 0.87%
15,000
– –
ABBV icon
27
AbbVie
ABBV
$443B
$948K 0.87%
7,000
– –
PFE icon
28
Pfizer
PFE
$143B
$945K 0.87%
16,000
-2,000
-11% -$99.1K
CVX icon
29
Chevron
CVX
$392B
$939K 0.86%
8,000
-1,000
-11% -$114K
BMY icon
30
Bristol-Myers Squibb
BMY
$133B
$935K 0.86%
15,000
+3,000
+25% +$176K
AMGN icon
31
Amgen
AMGN
$208B
$900K 0.83%
+4,000
New +$844K
PG icon
32
Procter & Gamble
PG
$336B
$900K 0.83%
5,500
-500
-8% -$74.2K
WU icon
33
Western Union
WU
$1.98B
$892K 0.82%
+50,000
New +$922K
LMT icon
34
Lockheed Martin
LMT
$134B
$889K 0.82%
2,500
+300
+14% +$104K
OHI icon
35
Omega Healthcare
OHI
$15.1B
$888K 0.81%
+30,000
New +$876K
GSK icon
36
GSK
GSK
$104B
$882K 0.81%
16,000
– –
MRK icon
37
Merck
MRK
$322B
$881K 0.81%
11,500
-500
-4% -$39.8K
JPM icon
38
JPMorgan Chase
JPM
$935B
$871K 0.8%
5,500
– –
PEP icon
39
PepsiCo
PEP
$190B
$869K 0.8%
5,000
-500
-9% -$81.7K
RDS.A
40
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$868K 0.8%
20,000
– –
PRU icon
41
Prudential Financial
PRU
$42.4B
$866K 0.79%
8,000
– –
UNM icon
42
Unum
UNM
$13.6B
$860K 0.79%
35,000
+2,000
+6% +$51.2K
XOM icon
43
ExxonMobil
XOM
$644B
$857K 0.79%
14,000
-1,000
-7% -$62.5K
JNJ icon
44
Johnson & Johnson
JNJ
$618B
$855K 0.78%
5,000
– –
PM icon
45
Philip Morris
PM
$297B
$855K 0.78%
9,000
– –
VRNS icon
46
Varonis Systems
VRNS
$4.59B
$854K 0.78%
17,500
-12,500
-42% -$712K
MO icon
47
Altria Group
MO
$114B
$853K 0.78%
18,000
+1,000
+6% +$45.8K
DOW icon
48
Dow Inc
DOW
$21.9B
$851K 0.78%
15,000
+2,000
+15% +$114K
ARCC icon
49
Ares Capital
ARCC
$13.5B
$848K 0.78%
40,000
– –
ABT icon
50
Abbott
ABT
$183B
$844K 0.77%
6,000
– –
1
2
3

Similar funds

EIM
Emmett Investment Management New York $131M AUM 25.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
LC
LTG Capital Newton, Massachusetts $131M AUM 19.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
OIM
Oder Investment Management Woodland Hills, California $130M AUM 25.54% 1-Year Est. Return
EPI
Eddie Patel Inc Chicago, Illinois $130M AUM

P.A.W. Capital's Q4 2021 Portfolio in Review

As of Q4 2021, P.A.W. Capital held 68 positions worth $109M, down 3% from $112M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

P.A.W. Capital's Q4 2021 filing shows 5 new, 17 increased, 21 reduced and 8 closed positions. Its largest new stake was ON24: 150,000 shares worth $2.6M. The largest sale was Ambarella, an estimated $1.85M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 33% a quarter earlier, followed by Communication Services and Healthcare.

  • P.A.W. Capital's largest Q4 2021 buy was ON24: 150,000 shares worth $2.6M.
  • P.A.W. Capital added most to Magnite in Q4 2021, an estimated $3.38M increase.
  • P.A.W. Capital's biggest Q4 2021 reduction was Ambarella, cutting an estimated $1.85M.
  • P.A.W. Capital fully exited Iovance Biotherapeutics in Q4 2021, selling an estimated $1.85M.
  • P.A.W. Capital's ten largest holdings make up 48% of its $109M portfolio in Q4 2021.
  • P.A.W. Capital opened 5 new positions and closed 8 in Q4 2021.
  • P.A.W. Capital's portfolio value fell 3% quarter-over-quarter to $109M.

Based on P.A.W. Capital's 13F filing for Q4 2021, filed 10 Feb 2022.